Search results
Results From The WOW.Com Content Network
June 25, 2024 at 3:43 PM. Andre Penner. The Centers for Disease Control and Prevention issued a health advisory Tuesday alerting authorities, health care providers and the public of the increased ...
Amid the surge in cases, the CDC is urging health care providers to be vigilant and test people who have fevers and have been in "areas with frequent or continuous dengue transmission within 14 ...
The CDC issued a Health Alert Network advisory on June 25 urging doctors to be aware of the rise in cases and to test people who report symptoms of fever and chills and who have recently traveled ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [ 9] Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. [ 10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [ 11][ 12]
Dengue virus. Dengue virus ( DENV) is the cause of dengue fever. It is a mosquito -borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [ 1][ 2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [ 3][ 4][ 5] all of which can cause the full spectrum of disease. [ 1]
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic; if symptoms appear they typically begin 3 to 14 days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin itching and skin rash.
June 26, 2024 at 2:08 PM. Federal health officials issued a warning over the increased risk of dengue fever around the world — with nearly 10 million reported cases this year in the Americas ...
Symptoms include fever, nausea, vomiting, rash, muscle aches, joint and bone pain, pain behind the eyes, headache and low white blood cell counts. Cases of severe dengue with bleeding, shock and ...